BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35672279)

  • 1. Mesenchymal chondrosarcoma of the head and neck with HEY1::NCOA2 fusion: A clinicopathologic and molecular study of 13 cases with emphasis on diagnostic pitfalls.
    Xu B; Rooper LM; Dermawan JK; Zhang Y; Suurmeijer AJH; Dickson BC; Demicco EG; Antonescu CR
    Genes Chromosomes Cancer; 2022 Nov; 61(11):670-677. PubMed ID: 35672279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic involvement by mesenchymal chondrosarcoma harboring the HEY1-NCOA2 gene fusion.
    Cohen JN; Solomon DA; Horvai AE; Kakar S
    Hum Pathol; 2016 Dec; 58():35-40. PubMed ID: 27544802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal chondrosarcoma diagnosed on FISH for HEY1-NCOA2 fusion gene.
    Moriya K; Katayama S; Onuma M; Rikiishi T; Hosaka M; Watanabe M; Hasegawa T; Sasahara Y; Kure S
    Pediatr Int; 2014 Oct; 56(5):e55-7. PubMed ID: 25336010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic profiling identifies genes and pathways dysregulated by HEY1-NCOA2 fusion and shines a light on mesenchymal chondrosarcoma tumorigenesis.
    Qi W; Rosikiewicz W; Yin Z; Xu B; Jiang H; Wan S; Fan Y; Wu G; Wang L
    J Pathol; 2022 Aug; 257(5):579-592. PubMed ID: 35342947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minute mesenchymal chondrosarcoma within osteochondroma: an unexpected diagnosis confirmed by HEY1-NCOA2 fusion.
    Toki S; Motoi T; Miyake M; Kobayashi E; Kawai A; Yoshida A
    Hum Pathol; 2018 Nov; 81():255-260. PubMed ID: 29596896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome aberrations and HEY1-NCOA2 fusion gene in a mesenchymal chondrosarcoma.
    Panagopoulos I; Gorunova L; Bjerkehagen B; Boye K; Heim S
    Oncol Rep; 2014 Jul; 32(1):40-4. PubMed ID: 24839999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data.
    Wang L; Motoi T; Khanin R; Olshen A; Mertens F; Bridge J; Dal Cin P; Antonescu CR; Singer S; Hameed M; Bovee JV; Hogendoorn PC; Socci N; Ladanyi M
    Genes Chromosomes Cancer; 2012 Feb; 51(2):127-39. PubMed ID: 22034177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are meningeal hemangiopericytoma and mesenchymal chondrosarcoma the same?: a study of HEY1-NCOA2 fusion.
    Fritchie KJ; Jin L; Ruano A; Oliveira AM; Rubin BP
    Am J Clin Pathol; 2013 Nov; 140(5):670-4. PubMed ID: 24124145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of HEY1-NCOA2 fusion by fluorescence in-situ hybridization in formalin-fixed paraffin-embedded tissues as a possible diagnostic tool for mesenchymal chondrosarcoma.
    Nakayama R; Miura Y; Ogino J; Susa M; Watanabe I; Horiuchi K; Anazawa U; Toyama Y; Morioka H; Mukai M; Hasegawa T
    Pathol Int; 2012 Dec; 62(12):823-6. PubMed ID: 23252872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel low-grade renal spindle cell neoplasm with HEY1::NCOA2 fusion that is distinct from mesenchymal chondrosarcoma.
    Miller TI; Mantilla JG; Wang W; Liu YJ; Tretiakova M
    Genes Chromosomes Cancer; 2023 Mar; 62(3):171-175. PubMed ID: 36416671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-derived xenografts and in vitro model show rationale for imatinib mesylate repurposing in HEY1-NCoA2-driven mesenchymal chondrosarcoma.
    Safaric Tepes P; Segovia D; Jevtic S; Ramirez D; Lyons SK; Sordella R
    Lab Invest; 2022 Sep; 102(9):1038-1049. PubMed ID: 34837064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OLIG2 Immunolabeling of Mesenchymal Chondrosarcoma: Report of 14 Cases.
    Yao K; Duan Z; Yang S; Du Z; Wang Y; Qi X
    J Neuropathol Exp Neurol; 2020 Sep; 79(9):959-965. PubMed ID: 32770197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary intradural extramedullary spinal mesenchymal chondrosarcoma: case report and literature review.
    Chen CW; Chen IH; Hu MH; Lee JC; Huang HY; Hong RL; Yang SH
    BMC Musculoskelet Disord; 2019 Sep; 20(1):408. PubMed ID: 31484514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of mesenchymal chondrosarcoma in pleural effusion with immunocytochemistry and determination of HEY1::NCOA2 fusion by next-generation sequencing on cell block.
    Zhong J; Wang Q; Xie Y; Niu Z; Zhou D
    Cytopathology; 2024 Jan; 35(1):149-152. PubMed ID: 37688410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HEY1-NCOA2 expression modulates chondrogenic differentiation and induces mesenchymal chondrosarcoma in mice.
    Tanaka M; Homme M; Teramura Y; Kumegawa K; Yamazaki Y; Yamashita K; Osato M; Maruyama R; Nakamura T
    JCI Insight; 2023 May; 8(10):. PubMed ID: 37212282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mesenchymal chondrosarcoma in central nervous system: a clinicopathological analysis].
    Huang Q; Chen YP; Song FL; Zheng LM; Liu XY; Zhang S; Wang XF
    Zhonghua Bing Li Xue Za Zhi; 2021 Aug; 50(8):870-875. PubMed ID: 34344069
    [No Abstract]   [Full Text] [Related]  

  • 17. Intraparenchymal mesenchymal chondrosarcoma of the frontal lobe--a case report and molecular detection of specific gene fusions from archival FFPE sample.
    Sajjad EA; Sikora K; Paciejewski T; Garbicz F; Paskal W; Szacht M; Grajkowska W; Włodarski PK
    Clin Neuropathol; 2015; 34(5):288-93. PubMed ID: 25907264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracranial Mesenchymal Chondrosarcoma Lacking the Typical Histopathological Features Diagnosed by
    Uneda A; Kurozumi K; Fujimura A; Kamiya A; Hirose T; Yanai H; Date I
    NMC Case Rep J; 2020 Apr; 7(2):47-52. PubMed ID: 32322450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
    Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Rushing EJ
    Hum Pathol; 2010 May; 41(5):653-62. PubMed ID: 20138330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NKX3.1 immunohistochemistry and methylome profiling in mesenchymal chondrosarcoma: additional diagnostic value for a well-defined disease?
    Glauser S; Ameline B; Andrei V; Harder D; Pauli C; Trautmann M; Hartmann W; Baumhoer D
    Pathology; 2023 Aug; 55(5):621-628. PubMed ID: 37225644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.